- $10.18bn
- $14.95bn
- $4.26bn
- 48
- 37
- 71
- 51
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,518 | 3,094 | 3,998 | 4,802 | 4,263 |
Cost of Revenue | |||||
Gross Profit | 805 | 983 | 1,352 | 1,614 | 1,040 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,260 | 2,716 | 3,188 | 4,076 | 4,426 |
Operating Profit | 258 | 378 | 810 | 726 | -163 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 160 | 260 | 715 | 579 | -342 |
Provision for Income Taxes | |||||
Net Income After Taxes | 137 | 221 | 585 | 499 | -256 |
Net Income Before Extraordinary Items | |||||
Net Income | 137 | 221 | 585 | 499 | -256 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 137 | 173 | 529 | 483 | -256 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.15 | 1.29 | 2.41 | 2.93 | -0.071 |